Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-12129237-B2 · Oct 29, 2024 · US
This page is not indexed by search engines while we improve data quality.
Elsner Jan patents
Elsner Jan is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Elsner Jan |
| Total patents | 28 |
| First publication | Feb 19, 2015 |
| Latest publication | Oct 29, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2023119470-A1 · Apr 20, 2023 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-2023116093-A1 · Apr 13, 2023 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-11325890-B2 · May 10, 2022 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-11292796-B2 · Apr 5, 2022 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-2021114992-A1 · Apr 22, 2021 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-10919865-B2 · Feb 16, 2021 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2020262840-A1 · Aug 20, 2020 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-10683298-B2 · Jun 16, 2020 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-2019194144-A1 · Jun 27, 2019 · US
Recent patents
Latest publications not already listed above.
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-10266500-B2 · Apr 23, 2019 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2019077806-A1 · Mar 14, 2019 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-10167290-B2 · Jan 1, 2019 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-2018305322-A1 · Oct 25, 2018 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-10040770-B2 · Aug 7, 2018 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2017342080-A1 · Nov 30, 2017 · US
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
US-9795607-B2 · Oct 24, 2017 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-9771371-B2 · Sep 26, 2017 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-2017267647-A1 · Sep 21, 2017 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-9701643-B2 · Jul 11, 2017 · US
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
US-9428509-B2 · Aug 30, 2016 · US
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
US-9346812-B2 · May 24, 2016 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2016024101-A1 · Jan 28, 2016 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-2015336901-A1 · Nov 26, 2015 · US
Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
US-9193692-B2 · Nov 24, 2015 · US
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
US-9139534-B2 · Sep 22, 2015 · US
Methods of synthesis and purification of heteroaryl compounds
US-9079900-B2 · Jul 14, 2015 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2015051397-A1 · Feb 19, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Signal Pharm Llc | 28 |
| Signal Pharmaceutical Llc | 3 |
| Bennett Brydon L | 1 |
| Elsner Jan | 1 |
| Erdman Paul | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.